Biomerica Inc

Research Biomerica Inc (BMRA) on Bullrun: market cap USD 5.47M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 5.47M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 5.31M-USD 4.97M-USD 2.97M9.4%-2.16USD 3.06MUSD 284.00KUSD 4.11M
FY2024USD 5.42M-USD 5.98M-USD 5.41M11.3%-2.84USD 4.17MUSD 626.00KUSD 6.59M
FY2023USD 5.34M-USD 7.14M-USD 5.54M8.4%-0.5USD 9.72MUSD 937.00KUSD 11.72M
FY2022USD 18.87M-USD 4.53M-USD 536.00K15.8%-0.36USD 5.92MUSD 1.38MUSD 8.33M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 5.47Mn/an/an/a
20252025-12-31USD 7.43Mn/an/an/a
20242024-12-31USD 5.50Mn/an/an/a
20232023-12-29USD 21.03Mn/an/an/a
20222022-12-30USD 45.16Mn/an/an/a
20212021-12-31USD 49.37Mn/an/an/a

About Biomerica Inc

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Biomerica Inc's market cap?

Biomerica Inc's market capitalization is USD 5.47M.

What does Biomerica Inc do?

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide.